“Stability of Long-Term Therapeutic Responses to Tralokinumab in Adults with Moderate-to-Severe Atopic Dermatitis” (2024) SKIN The Journal of Cutaneous Medicine, 8(4), p. s412. doi:10.25251/skin.8.supp.412.